• Set to double EBITDA in next 2 years
• 95% of revenue from repeat customers
• 615 orders in 2020

• Robust Intellectual Property:
• 7 Patents
• 1 Patent Pending
• 1 Trademark

• Backlog of $3.8 million
• Strong design and utility patent portfolio
• Long-standing relationship with customer base

The Company is the only worldwide manufacturer of components for a proprietary plastic capsule developed in conjunction with its largest customer, who owns the design patent. The capsule, designed to contain a sensor for continuous glucose monitoring, is responsible for the majority of sales. There are different versions of this product approved for sale in Europe and the US, as well as other versions currently in research and development for an expanded product line.